WST

WST Investing Cash Flow

-$225.30MTTM · USD

Period ending:

WST FY Cash from InvestingUSD
WST FY Cash from Investing1989-12-31: -$39.30M1990-12-31: -$31.60M1991-12-31: -$24.50M1992-12-31: -$14.90M1993-12-31: -$25.50M1994-12-31: -$37.30M1995-12-31: -$100.60M1996-12-31: -$24.50M1997-12-31: -$33.00M1998-12-31: -$73.80M1999-12-31: -$61.70M2000-12-31: -$60.50M2001-12-31: -$15.40M2002-12-31: -$32.30M2003-12-31: -$57.10M2004-12-31: -$24.50M2005-12-31: -$227.40M2006-12-31: -$89.90M2007-12-31: -$155.90M2008-12-31: -$128.20M2009-12-31: -$121.90M2010-12-31: -$74.00M2011-12-31: -$120.50M2012-12-31: -$116.00M2013-12-31: -$149.90M2014-12-31: -$104.00M2015-12-31: -$129.50M2016-12-31: -$175.80M2017-12-31: -$133.60M2018-12-31: -$100.80M2019-12-31: -$228.00M2020-12-31: -$179.50M2021-12-31: -$253.10M2022-12-31: -$288.20M2023-12-31: -$368.70M2024-12-31: -$378.70M2025-12-31: -$285.90M$0.00-$378.70M
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

WST investing cash flow history

Cash used for investments in assets and securities. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

West Pharmaceutical Services Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
-285,900,000
-378,700,000
-368,700,000
-288,200,000
-253,100,000
-179,500,000
-228,000,000
-100,800,000
-133,600,000
-175,800,000
-129,500,000
-104,000,000
-149,900,000
-116,000,000
-120,500,000
-74,000,000
-121,900,000
-128,200,000
-155,900,000
-89,900,000
-227,400,000
-24,500,000
-57,100,000
-32,300,000
-15,400,000
-60,500,000
-61,700,000
-73,800,000
-33,000,000
-24,500,000
-100,600,000
-37,300,000
-25,500,000
-14,900,000
-24,500,000
-31,600,000
-39,300,000

Compare investing cash flow

All WST financial metrics · WST stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.